Organon & Co. (OGN) concluded trading on Wednesday at a closing price of $19.97, with 3.86 million shares of worth about $77.15 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.32% during that period and on September 18, 2024 the price saw a loss of about -2.82%. Currently the company’s common shares owned by public are about 257.47M shares, out of which, 256.93M shares are available for trading.
Stock saw a price change of -0.94% in past 5 days and over the past one month there was a price change of -4.72%. Year-to-date (YTD), OGN shares are showing a performance of 38.49% which increased to 2.62% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $10.84 but also hit the highest price of $23.10 during that period. The average intraday trading volume for Organon & Co. shares is 1.62 million. The stock is currently trading -6.34% below its 20-day simple moving average (SMA20), while that difference is down -4.91% for SMA50 and it goes to 7.52% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Organon & Co. (NYSE: OGN) currently have 257.47M outstanding shares and institutions hold larger chunk of about 80.41% of that.
The stock has a current market capitalization of $5.14B and its 3Y-monthly beta is at 0.82. PE ratio of stock for trailing 12 months is 5.14, while it has posted earnings per share of $3.89 in the same period. Its PEG reads 1.66 and has Quick Ratio of 1.17 while making debt-to-equity ratio of 60.11. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OGN, volatility over the week remained 3.15% while standing at 2.98% over the month.
Stock’s fiscal year EPS is expected to rise by 5.46% while it is estimated to increase by 4.15% in next year. EPS is likely to grow at an annualized rate of 3.10% for next 5-years, compared to annual growth of -14.04% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by JP Morgan on September 06, 2024 offering an Underweight rating for the stock and assigned a target price range of between $18 and $20 to it. Coverage by Goldman stated Organon & Co. (OGN) stock as a Neutral in their note to investors on November 03, 2023, suggesting a price target of $16 for the stock. On September 21, 2023, Barclays Initiated their recommendations, while on March 16, 2023, Raymond James Initiated their ratings for the stock with a price target of $33. Stock get an Underperform rating from BofA Securities on October 14, 2022.
